ATE411993T1 - Muscarine agonisten als therapeutische verbindungen - Google Patents

Muscarine agonisten als therapeutische verbindungen

Info

Publication number
ATE411993T1
ATE411993T1 AT04805924T AT04805924T ATE411993T1 AT E411993 T1 ATE411993 T1 AT E411993T1 AT 04805924 T AT04805924 T AT 04805924T AT 04805924 T AT04805924 T AT 04805924T AT E411993 T1 ATE411993 T1 AT E411993T1
Authority
AT
Austria
Prior art keywords
therapeutic compounds
agonists
muscarine
muscarine agonists
stimulating
Prior art date
Application number
AT04805924T
Other languages
English (en)
Inventor
Maxime Buffat
Eric James Thomas
Robin Havard Davies
Original Assignee
Muscagen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Muscagen Ltd filed Critical Muscagen Ltd
Application granted granted Critical
Publication of ATE411993T1 publication Critical patent/ATE411993T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT04805924T 2003-12-05 2004-12-06 Muscarine agonisten als therapeutische verbindungen ATE411993T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0328295.1A GB0328295D0 (en) 2003-12-05 2003-12-05 Therapeutic compounds

Publications (1)

Publication Number Publication Date
ATE411993T1 true ATE411993T1 (de) 2008-11-15

Family

ID=29764691

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04805924T ATE411993T1 (de) 2003-12-05 2004-12-06 Muscarine agonisten als therapeutische verbindungen

Country Status (7)

Country Link
US (1) US7691857B2 (de)
EP (1) EP1697359B1 (de)
JP (1) JP2007513136A (de)
AT (1) ATE411993T1 (de)
DE (1) DE602004017354D1 (de)
GB (1) GB0328295D0 (de)
WO (1) WO2005054242A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8314391D0 (en) * 1983-05-24 1983-06-29 Kefalas As Heterocyclic compounds
EP0517812A4 (en) * 1990-02-13 1995-10-18 Merck & Co Inc Angiotensin ii antagonists incorporating a substituted benzyl element
FR2663929A1 (fr) * 1990-06-29 1992-01-03 Adir Nouveaux derives d'oxazolo pyridines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
NZ521978A (en) * 2000-04-28 2004-10-29 Acadia Pharm Inc Compounds that affect cholinergic receptors and are particularly muscarinic agonists

Also Published As

Publication number Publication date
JP2007513136A (ja) 2007-05-24
EP1697359B1 (de) 2008-10-22
WO2005054242A1 (en) 2005-06-16
GB0328295D0 (en) 2004-01-07
US7691857B2 (en) 2010-04-06
DE602004017354D1 (de) 2008-12-04
US20080039469A1 (en) 2008-02-14
EP1697359A1 (de) 2006-09-06

Similar Documents

Publication Publication Date Title
ATE433447T1 (de) Pyrimiidinverbindungen
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
EA200701114A1 (ru) Азоловые производные с антимускариновой активностью
EA200301213A1 (ru) Лиганды рецепторов 5-ht и их применение
CR9223A (es) 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen
DK1379246T3 (da) Nocieptin-analoger
ATE384061T1 (de) Imidazo- und thiazolopyridine als jak3-kinase- inhibitoren
NO20062950L (no) 5,7-diaminopyrazolo `43-Dlpyrimidiner med PDE-5 inhiberende aktivitet
BRPI0510177B8 (pt) composto, composição farmacêutica e uso do mesmo
MX2007003108A (es) Compuestos imidazo-3-il-amina sustituidos y biciclicos.
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
ATE365740T1 (de) Substituierte pyrazolopyrimidine
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
EA200870360A1 (ru) Бензимидазолы, обладающие активностью в отношении рецепторов м1, и их применение в медицине
ATE493418T1 (de) Dihydrofuropyrimidine als akt- proteinkinaseinhibitoren
UY29197A1 (es) Compuestos de n-sulfonilaminobencil-2-fenoxiacetamida sustituidos
ATE532789T1 (de) Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren
ATE384039T1 (de) Indanderivate als muscarinrezeptoragonisten
UY28333A1 (es) Inhibidores de caspasa y sus usos.
CL2007002899A1 (es) Compuestos derivados de azaciclilaminas n-sustituidas, inhibidores del receptor de histamina 3; proceso de preparacion; composicion farmaceutica que comprende los compuestos, y usopara el tratamiento de trastornos cognitivos, esquizofre nia y enfermedad de alzheimer entre otros.
BRPI0519267A2 (pt) derivado de quinolina, seu uso, produÇço e medicamento contendo o mesmo
ATE438398T1 (de) Pyrrolo-dihydroisochinolin-derivate als pde10- inhibitoren
ATE542796T1 (de) N-sulfonylcarboximidamidverbindungen als apoptosepromotoren
BRPI0409376A (pt) derivados de indeno como agentes farmacêuticos
ATE370955T1 (de) N-sulfonylheterocyclopyrrolylalkylamin verbindungen als 5-hydroxytryptamin-6 liganden.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties